Holen Sie sich die Stockscreener-App
23.35
3.39%
-0.82
Immunome Inc Aktie (IMNM) Neueste Nachrichten
What Do Recent Insider Sales at Immunome (IMNM) Signal - Kavout | AI
Why Immunome (IMNM) Is Up 11.7% After FDA Accepts Varegacestat NDA For Desmoid Tumors - Sahm
Immunome Stock Up 32% in a Month: Here's What You Should Know - Yahoo Finance Singapore
symbol__ Stock Quote Price and Forecast - CNN
Form 4 Immunome Inc For: 9 July By Investing.com - Investing.com South Africa
Immunome CBO Horn Kinney sells $27,300 in stock By Investing.com - Investing.com South Africa
Truist Financial Maintains Immunome(IMNM.US) With Buy Rating - Moomoo
Immunome CBO Horn Kinney sells $27,300 in stock - Investing.com UK
Immunome Inc. (IMNM) CBO exercises options and sells 1,092 shares - Stock Titan
H.C. Wainwright reiterates Immunome stock rating on FDA filing By Investing.com - Investing.com India
Immunome Clears Key Regulatory Milestone as Lead Drug Goes Under FDA Review - Benzinga
Immunome secures FDA review for cancer drug varegacestat - grafa.com
LifeSci Capital Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Immunome granted FDA review for tumor candidate (IMNM:NASDAQ) - Seeking Alpha
FDA accepts Immunome NDA for desmoid tumor treatment varegacestat - Investing.com
FDA accepts Immunome NDA for desmoid tumor treatment varegacestat By Investing.com - Investing.com India
Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors - Caledonian Record
Price-Driven Insight from (IMNM) for Rule-Based Strategy - Stock Traders Daily
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 7, 2026 - BioSpace
Immunome director Isaac Barchas sells $2.4m in shares, price $24.11-$24.20 - Investing.com
Form 4 Immunome Inc For: 7 July By Investing.com - Investing.com Nigeria
Immunome director Isaac Barchas sells $2.4m in shares, price $24.11-$24.20 By Investing.com - Investing.com South Africa
Form 144 Immunome Inc. For: 7 July By Investing.com - Investing.com India
Entity tied to Immunome (IMNM) director sells 100K shares - Stock Titan
Immunome CMO Robert Lechleider sells $1.24m in company stock - Investing.com
Immunome CMO Robert Lechleider sells $1.24m in company stock By Investing.com - Investing.com Nigeria
Immunome (IMNM) CMO exercises 55K options and sells 55K shares under 10b5-1 plan - Stock Titan
[144] Immunome Inc. SEC Filing - Stock Titan
Form 144 Immunome For: 6 July By Investing.com - Investing.com Nigeria
IMNM (Nasdaq) affiliate filings report multiple share sales, including 100,000-share entries - Stock Titan
Immunome's $4.39 Million Insider Sale: A Pre-Planned Exit Amidst Robust Pipeline Momentum - Kavout | AI
Immunome(IMNM.US) Director Sells US$4.39 Million in Common Stock - Moomoo
Form 4 Immunome Inc For: 2 July By Investing.com - Investing.com Nigeria
Immunome director Barchas sells $4.39m in common stock By Investing.com - Investing.com India
Director-linked entities trim Immunome (IMNM) stake with 201,050-share sale - Stock Titan
Immunome director Barchas sells $4.39m in common stock - Investing.com
Form 144 Immunome For: 2 July By Investing.com - Investing.com UK
IMNM (Nasdaq: IMNM) Rule 144 entries show 100,000-share block - Stock Titan
Form 144 Immunome Inc. For: 2 July By Investing.com - Investing.com UK
IMNM (NASDAQ: IMNM) affiliate files to sell 55,000 shares on 07/02/2026 - Stock Titan
Is Immunome’s (IMNM) Russell Exit Quietly Recasting Its Shareholder Base And Liquidity Story? - simplywall.st
Form 144 Immunome For: 30 June By Investing.com - Investing.com South Africa
J.P. Morgan Maintains Immunome(IMNM.US) With Buy Rating - Moomoo
Immunome CMO Robert Lechleider sells $1.09m in stock By Investing.com - Investing.com South Africa
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):